KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Pacira BioSciences (PCRX) Leases (2019 - 2025)

Historic Leases for Pacira BioSciences (PCRX) over the last 10 years, with Q3 2025 value amounting to $44.3 million.

  • Pacira BioSciences' Leases fell 1776.7% to $44.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year decrease of 1776.7%. This contributed to the annual value of $49.2 million for FY2024, which is 1933.46% down from last year.
  • Per Pacira BioSciences' latest filing, its Leases stood at $44.3 million for Q3 2025, which was down 1776.7% from $46.5 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Leases registered a high of $76.4 million during Q4 2021, and its lowest value of $44.3 million during Q3 2025.
  • In the last 5 years, Pacira BioSciences' Leases had a median value of $65.8 million in 2023 and averaged $62.8 million.
  • Its Leases has fluctuated over the past 5 years, first skyrocketed by 9378.41% in 2021, then crashed by 1933.46% in 2024.
  • Pacira BioSciences' Leases (Quarter) stood at $76.4 million in 2021, then dropped by 7.24% to $70.9 million in 2022, then dropped by 13.91% to $61.0 million in 2023, then dropped by 19.33% to $49.2 million in 2024, then decreased by 10.07% to $44.3 million in 2025.
  • Its Leases was $44.3 million in Q3 2025, compared to $46.5 million in Q2 2025 and $48.7 million in Q1 2025.